Acer Therapeutics Inc. (NASDAQ: ACER) flaunted slowness of -2.44% at $3.99, as the Stock market unbolted on February 11, 2021. During the day, the stock rose to $4.59 and sunk to $3.90 before settling in for the price of $4.09 at the close. Taking a more long-term approach, ACER posted a 52-week range of $1.08-$7.25.
Meanwhile, its Annual Earning per share during the time was 42.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -17.20%. This publicly-traded company’s shares outstanding now amounts to $11.51 million, simultaneously with a float of $11.21 million. The organization now has a market capitalization sitting at $58.09 million. At the time of writing, stock’s 50-day Moving Average stood at $3.07, while the 200-day Moving Average is $3.09.
Acer Therapeutics Inc. (ACER) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Acer Therapeutics Inc. industry. Acer Therapeutics Inc.’s current insider ownership accounts for 25.21%, in contrast to 31.60% institutional ownership. According to the most recent insider trade that took place on Jul 24, this organization’s Director bought 45,000 shares at the rate of 3.50, making the entire transaction reach 157,500 in total value, affecting insider ownership by 63,905. Preceding that transaction, on Jul 24, Company’s Chief Legal Officer and Secy bought 14,285 for 3.50, making the whole transaction’s value amount to 49,998. This particular insider is now the holder of 14,285 in total.
Acer Therapeutics Inc. (ACER) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.51 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.46) by -$0.05. This company achieved a return on equity of -92.72. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
Acer Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -17.20% and is forecasted to reach -1.65 in the upcoming year.
Acer Therapeutics Inc. (NASDAQ: ACER) Trading Performance Indicators
Let’s observe the current performance indicators for Acer Therapeutics Inc. (ACER). It’s Quick Ratio in the last reported quarter now stands at 1.60. The Stock has managed to achieve an average true range (ATR) of 0.44.
In the same vein, ACER’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.07, a figure that is expected to reach -0.41 in the next quarter, and analysts are predicting that it will be -1.65 at the market close of one year from today.
Technical Analysis of Acer Therapeutics Inc. (ACER)
Now, what If we examine the latest scores posted by [Acer Therapeutics Inc., ACER]. During the last 5-days, its volume was lower the volume of 1.64 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 54.20% While, its Average True Range was 0.44.
Raw Stochastic average of Acer Therapeutics Inc. (ACER) in the period of the previous 100 days is set at 68.15%, which indicates a major rise in contrast to 40.60% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 103.11% that was higher than 84.40% volatility it exhibited in the past 100-days period.